Title |
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
|
---|---|
Published in |
PLOS ONE, May 2012
|
DOI | 10.1371/journal.pone.0036966 |
Pubmed ID | |
Authors |
Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen |
Abstract |
We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 333 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 2% |
South Africa | 4 | 1% |
Brazil | 1 | <1% |
Unknown | 323 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 67 | 20% |
Student > Master | 56 | 17% |
Student > Ph. D. Student | 54 | 16% |
Student > Postgraduate | 22 | 7% |
Student > Bachelor | 21 | 6% |
Other | 53 | 16% |
Unknown | 60 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 124 | 37% |
Agricultural and Biological Sciences | 21 | 6% |
Nursing and Health Professions | 19 | 6% |
Social Sciences | 16 | 5% |
Immunology and Microbiology | 13 | 4% |
Other | 62 | 19% |
Unknown | 78 | 23% |